ClinicalTrials.Veeva

Menu

The Clinical Effect of Normal Diet and Absolute Diet on Post-polypectomy Patients: an Open-label, Randomized Controlled Trial

N

Nanfang Hospital, Southern Medical University

Status

Unknown

Conditions

Polyp Colorectal

Treatments

Dietary Supplement: normal diet
Dietary Supplement: absolute diet

Study type

Interventional

Funder types

Other

Identifiers

NCT03989791
NFEC-2017-080

Details and patient eligibility

About

There is no evidence to prove the impact of post-procedural diet on post-polypectomy bleeding (PPB) or delayed perforation. No relevant study has been conducted and it is yet to be determined if absolute diet is necessary for post-polypectomy patients, and the comparison between normal diet and absolute diet also remains unclear. Therefore, we carried out this randomized controlled study to evaluate and compare tthe clinical effect of different diets on post-polypectomy patients.

Enrollment

406 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18-75 patient with initial diagnosis of colorectal polyp by colonoscopy;
  2. The maximum size of polyp is more than 20mm;
  3. The patients underwent single ESD procedure for the polyp and agreed to participate this trial.

Exclusion criteria

  1. Uncontrollable hypertension or diabetes;
  2. Severe comorbidities such as cancer and organ failure etc;
  3. Patients who were pregnant;
  4. Patients had anticoagulants during perioperative period;
  5. Patients with poor compliance. -

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

406 participants in 2 patient groups

Absolute diet
Active Comparator group
Treatment:
Dietary Supplement: absolute diet
Normal diet
Experimental group
Treatment:
Dietary Supplement: normal diet

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems